InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review

Date: February 23, 2015
Pages: 19
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I764FFA7D98EN
Leaflet:

Download PDF Leaflet

InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review
InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

InfectoPharm Arzneimittel und Consilium GmbH (InfectoPharm) is a pharmaceutical company. It carries out the research, development, manufacture and marketing of medicines for pediatric infectious diseases. The company offers 75 products catering to the areas such as clinical infectious diseases, dermatology, pediatrics and pneumology. Its major product portfolio consists of oral antibiotics and antiparasitics. The company caters to the needs of children, pediatric physicians and adolescent patients. It also offers training services and education programs. The company also provides day nursery services, which are aimed at child welfare, child development and support to parents. The company markets its products and expands its product range through own distribution partners and outside partners. InfectoPharm is headquartered in Heppenheim, Germany.

The company's strategy is to expand its product range and foray into new markets through in-licensing and out-licensing.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

InfectoPharm Arzneimittel und Consilium GmbH - Key Facts
InfectoPharm Arzneimittel und Consilium GmbH - Key Employees
InfectoPharm Arzneimittel und Consilium GmbH - Major Products and Services
InfectoPharm Arzneimittel und Consilium GmbH - History
InfectoPharm Arzneimittel und Consilium GmbH - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

InfectoPharm Arzneimittel und Consilium GmbH - Business Description
InfectoPharm Arzneimittel und Consilium GmbH - SWOT Analysis
SWOT Analysis - Overview
InfectoPharm Arzneimittel und Consilium GmbH - Strengths
Strength - Broad Portfolio of Products
Strength - Competitive Market Position
Strength - Sturdy Research and Development Activities
InfectoPharm Arzneimittel und Consilium GmbH - Weaknesses
Weakness - Limited Geographical Operations
InfectoPharm Arzneimittel und Consilium GmbH - Opportunities
Opportunity - Global Dermatology Market
Opportunity - Market Potential: Asthma
Opportunity - Product Approval – Mupirocin
InfectoPharm Arzneimittel und Consilium GmbH - Threats
Threat - Competition and Technological Changes
Threat - Uncertain R&D Outcomes
Threat - Increased Drug Scrutiny
InfectoPharm Arzneimittel und Consilium GmbH - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
InfectoPharm Arzneimittel und Consilium GmbH, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

InfectoPharm Arzneimittel und Consilium GmbH, Key Facts
InfectoPharm Arzneimittel und Consilium GmbH, Key Employees
InfectoPharm Arzneimittel und Consilium GmbH, Major Products and Services
InfectoPharm Arzneimittel und Consilium GmbH, History
InfectoPharm Arzneimittel und Consilium GmbH, Key Competitors
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
InfectoPharm Arzneimittel und Consilium GmbH, Recent Deals Summary

LIST OF FIGURES

InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
InfectoPharm Arzneimittel und Consilium GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


H.C. Starck GmbH - Strategic SWOT Analysis Review US$ 125.00 Jan, 2016 · 23 pages

Ask Your Question

InfectoPharm Arzneimittel und Consilium GmbH - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: